Waters Corp. Updates Instruments and Software - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Waters Corp. Updates Instruments and Software


At Pittcon 2013 in Philadelphia, Waters Corp. announced improvement to chromatography systems and software.

The company reported enhancements to the Waters Alliance HPLC system that will maintain key Alliance performance specifications and control algorithms to ensure that analysts can replicate their existing methods. The system features updated electronics and user interface. The updated systems can be used with Waters eXtended Performance [XP], 2.5 μm columns.

The company also announced an expansion of its laboratory informatics offerings, with the addition of Paradigm Scientific Search Software, which allows users to perform object-based searches across both structured and unstructured data and across different data platforms.

Mobile access and new laboratory analytics enhancements were added to Empower 3 chromatography data software.

Quality Control Reference Materials (QCRMs) and Certified Containers for Waters instruments were added to the Analytical Standards and Reagents product group.

Another technology introduction is the Waters ACQUITY Advanced Polymer Chromatography (APC) System, the company says, defines a new category of chromatographic polymer analysis, yielding improved molecular weight information about polymeric species, faster than ever before.

Waters Corp. announced updates to the Alliance HPLC system and Empower 3 chromatography data software, and introduced search software and reference materials.

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
29%
Breakthrough designations
10%
Protecting the supply chain
43%
Expedited reviews of drug submissions
10%
More stakeholder involvement
10%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests

Click here